M05.04 Felty's syndrome, hand

Name of the Condition

• Felty's syndrome, hand

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). When affecting the hand, it involves chronic inflammation of the hand joints alongside systemic manifestations. The condition typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA). Hand involvement occurs as part of the broader rheumatoid arthritis process affecting multiple joints.

Risk Factors

• Long-standing, severe rheumatoid arthritis
• High titers of rheumatoid factor
• Presence of anti-citrullinated protein antibodies (ACPA)
• Advanced age (typically over 50 years)
• Female gender (more commonly affected)

Symptoms

• Persistent joint pain, swelling, and stiffness in the hand from underlying rheumatoid arthritis
• Fatigue and weakness
• Recurrent infections due to neutropenia
• Abdominal discomfort or fullness from splenomegaly
• Unexplained weight loss
• Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome, hand, requires confirmation of the triad of rheumatoid arthritis, splenomegaly, and neutropenia, with hand joint involvement documented. Clinical evaluation includes assessing hand joint inflammation, splenic size via imaging, and blood tests for neutrophil count. Additional tests may include rheumatoid factor and anti-citrullinated protein antibodies to support the rheumatoid arthritis diagnosis. Exclusion of other causes of neutropenia or splenomegaly is necessary.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and its complications. Disease-modifying antirheumatic drugs (DMARDs) are used to control joint inflammation. Granulocyte colony-stimulating factor (G-CSF) may address neutropenia, while antibiotics treat infections. Splenectomy is rarely considered. Hand-specific interventions include physical therapy, splints, or anti-inflammatory medications to manage joint symptoms.

Prognosis and Follow-Up

Prognosis depends on disease severity and response to treatment. Early intervention may improve outcomes, but long-standing disease can lead to persistent joint damage and infection risk. Regular follow-up monitors joint function, blood counts, and infection signs. Adjustments to therapy are made based on clinical and laboratory findings.

Complications

• Increased risk of serious infections due to neutropenia
• Progressive joint damage in the hand, leading to deformity or loss of function
• Anemia or thrombocytopenia in some cases
• Splenic rupture (rare)
• Reduced quality of life from chronic pain and fatigue

Lifestyle & Prevention

• Adhere to prescribed rheumatoid arthritis treatments to reduce systemic inflammation
• Practice good hand hygiene to minimize infection risk
• Use assistive devices or ergonomic modifications to protect hand joints
• Maintain a balanced diet and regular exercise to support overall health
• Avoid smoking, which may worsen rheumatoid arthritis

When to Seek Professional Help

Seek medical attention if you experience:

• Worsening hand joint pain, swelling, or stiffness
• Signs of infection (e.g., fever, chills, persistent sore throat)
• Unexplained fatigue or weight loss
• Abdominal pain or fullness suggesting splenomegaly
• New or worsening skin ulcers or discoloration

Tips for Medical Coders

Code M05.04 is specific to Felty's syndrome with hand involvement. Document the presence of rheumatoid arthritis, splenomegaly, and neutropenia, along with hand joint manifestations, to support accurate coding. Ensure clinical correlation between systemic and localized findings. Avoid coding hand involvement separately if it is part of the broader Felty's syndrome diagnosis.